Clinical Trial Update: Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of Bepirovirsen on cardiac conduction in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Bepirovirsen

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED